NOVEL CYTOTOXIC AGENTS THAT PREFERENTIALLY TARGET LEUKEMIA INHIBITORY FACTOR (LIF) FOR THE TREATMENT OF MALIGNANCIES AND AS NEW CONTRACEPTIVE AGENTS

• 收藏
• 分享

专利权人:

Evestra; Inc.

发明人:

NAIR, Hareesh,SANTHAMMA, Bindu,NICKISCH, Klaus

申请号：

EP16769548

公开号：

EP3273983A4

申请日:

2016.03.22

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

Described herein are new anti-cancer compounds and methods of using such compounds, acting through a new mechanism of action by simultaneous inhibition of leukemia inhibitory factor (LIF) and MDM2. In one embodiment, a cytotoxic compound has the structure (I) or (II). In an embodiment, a method of treating cancer in a subject comprising administering to a subject a medicament comprising an effective amount of a cytotoxic small molecule compound that inhibits leukemia inhibitory factor or leukemia inhibitory factor receptor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/